In this article, we will discuss the 5 best European dividend stocks to buy now.
Keep Reading →
October 7 - Hedge Funds, News
The diabetes market has grown in the past few years as organizations and individuals in the private and public domains make significant investments in the sector to generate awareness...
Keep Reading →
September 26 - Hedge Funds, News
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
Keep Reading →
September 5 - Lists, News
In this article, we discuss 10 undervalued high free cash flow stocks to buy amid recession.
Keep Reading →
August 1 - Hedge Funds, News
In this article, we discuss the 10 biotech stocks that investors are watching.
Keep Reading →
June 27 - Hedge Funds, News
In this article, we will look at 10 undervalued stocks in Ken Fisher's 2022 portfolio.
Keep Reading →
June 16 - Hedge Funds, News
In this article, we will look at the top 15 stocks sold by investing legend Mario Gabelli in Q1 2022.
Keep Reading →
May 26 - Hedge Funds, News
In this piece, we will take a look at the five biotechnology stocks to buy according to Ken Fisher's Fisher Asset Management.
Keep Reading →
April 13 - Hedge Funds, News
In this article, we discuss the 5 most profitable biotech companies in the world.
Keep Reading →
April 5 - Lists, News
In this piece, we will take a look at ten biotechnology stocks to buy according to billionaire DE Shaw.
Keep Reading →
April 2 - Hedge Funds, News
A whopping number of 13F filings filed with U.S.
Keep Reading →
January 14 - Hedge Funds, News
In this article, we discuss the 10 biotech stocks to buy according to billionaire Ken Fisher.
Keep Reading →
December 7 - Hedge Funds, News
In this article, we take a look at the top 10 dividend stocks to buy according to Bernard Horn's Polaris Capital.
Keep Reading →
December 2 - Hedge Funds, News
In this article, we will be taking a look at the 10 best diabetes stocks to buy now.
Keep Reading →
November 2 - Hedge Funds, News
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
October 25 - Hedge Funds, News
In this article, we discuss the 10 high-yield dividend stocks to buy according to Ken Fisher.
Keep Reading →
October 22 - Hedge Funds, News
In this article, we discuss the 10 stocks that just received a Sell rating from analysts.
Keep Reading →
September 21 - Hedge Funds, News
In this article, we discuss the 5 pharma companies making treatment for opioid overdose.
Keep Reading →
August 4 - Hedge Funds, News
In this article we discuss the 5 most valuable biotech companies in the world.
Keep Reading →
July 30 - Hedge Funds, News
In this article we discuss the 5 most valuable companies in Europe.
Keep Reading →
July 26 - Hedge Funds, News
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Keep Reading →
July 22 - Hedge Funds, News
In this article, we discuss the 10 best biotech penny stocks to buy now.
Keep Reading →
June 14 - Hedge Funds, News
In this article we discuss the 10 best dividend stocks to buy according to Cathie Wood.
Keep Reading →
May 27 - Hedge Funds, News
In this article we discuss the 5 best dividend stocks to buy according to Cathie Wood.
Keep Reading →
May 27 - Hedge Funds, News
In this article we will take a look at the 10 best biotech stocks to buy according to Cathie Wood.
Keep Reading →
May 25 - Hedge Funds, News
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money ...
Keep Reading →
April 24 - Hedge Funds, News
Oakmark Funds, a long-term value investment management firm, published its "Oakmark Global Fund" fourth quarter 2020 investor letter – a copy of which can be seen here.
Keep Reading →
March 29 - Hedge Fund Investor Letters, News
In this article we will take a look at the 10 best pharma stocks to buy now.
Keep Reading →
March 25 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
October 6 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 13 - Hedge Funds, News
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...
Keep Reading →
June 12 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
May 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
March 12 - Hedge Funds, News
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Keep Reading →
December 26 - Hedge Funds, News
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Keep Reading →
December 4 - Hedge Funds, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
October 7 - Hedge Funds, News
Before we spend countless hours researching a company, we'd like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
June 7 - Hedge Funds, News
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events...
Keep Reading →
March 25 - Hedge Funds, News
The elite funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous resources...
Keep Reading →
December 10 - Hedge Funds, News
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
Keep Reading →
November 13 - Dividend Stocks, Hedge Funds, News
ZURICH (Reuters) - Nestle (NESN.S) Chief Executive Mark Schneider said he was convinced the food giant had the right strategy in place to further improve sales and profitability...
Keep Reading →
July 26 - Hedge Funds, Insider Trading
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
Keep Reading →
March 22 - News
Curious to know which treatments are among the 15 bestselling most profitable drugs of all time? The pharmaceutical industry has been a topic of interest for investors, market...
Keep Reading →
November 24 - News
The top 10 largest pharmaceutical companies by revenue in 2017 are leading companies that have a large geographical presence, loyal customer base and technologically advanced ...
Keep Reading →
November 23 - News
Out of the 10 companies on this list, four are from Switzerland, while three are from Germany, reflective of the favorable position of the two countries in Europe’s economic...
Keep Reading →
April 17 - Earnings Report, Lists, News
Let’s focus on the 10 most advanced technologies in the world today, to highlight the great job done by our scientists and innovators.
Keep Reading →
April 5 - Lists, News
After recently getting the approval of the U.S.
Keep Reading →
March 16 - News, Stock Analysis
A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira biosimilar.
Keep Reading →
March 8 - News, Stock Analysis
Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to induce them to recommend...
Keep Reading →
March 3 - News, Stock Analysis
A few weeks ago, President Donald Trump met with a series of biotech CEOs to discuss a historically major pain point for the industry: cutting the FDA drug approval process "at...
Keep Reading →
February 23 - News, Stock Analysis